Prime Medicine, Inc. (PRME) — 10-Q Filings
All 10-Q filings from Prime Medicine, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
- 10-Q Filing — May 7, 2026
-
Prime Medicine Narrows Q3 Loss, Boosts Cash with $138M Offering
— Nov 7, 2025 Risk: medium
Prime Medicine, Inc. reported a net loss of $50.58 million for the three months ended September 30, 2025, a slight improvement from the $52.52 million net loss -
Prime Medicine's Losses Widen Amid Heavy R&D Spend
— Aug 7, 2025 Risk: high
Prime Medicine, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-commercial stage. The company posted a net lo -
Prime Medicine Files Q1 2025 10-Q
— May 8, 2025 Risk: low
Prime Medicine, Inc. filed its 10-Q for the period ending March 31, 2025. The company, focused on biological products, reported its financial status for the fir -
Prime Medicine, Inc. Files 10-Q for Period Ending March 31, 2024
— May 10, 2024 Risk: medium
Prime Medicine, Inc. (PRME) filed a Quarterly Report (10-Q) with the SEC on May 10, 2024. Prime Medicine, Inc. reported financial results for the quarter ended
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX